fbpx

World Pharma News

12

Jan2021
On January 9, 2020, the Food and Drug Administration approved avapritinib (AYVAKITTM, Blueprint Medicines Corporation) for adults with ... Read More

12

Jan2021
The FDA decision on dapaglifozin for CKD is expected in the second quarter of 2021.... Read More

11

Jan2021
After submitting an IND less than a month ago, biopharma company Neoleukin was benched by the FDA with ... Read More

11

Jan2021
The U.S. Food and Drug Administration is alerting clinical laboratory staff and health care providers that the FDA ... Read More
X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X